About
Your partner in diabetes
At Medtronic, we make products that help people with diabetes live more fully, more freely, and with greater confidence. We’ve been delivering groundbreaking advancements in technology for over four decades.
Who we are
When it comes to diabetes care, it's personal for us.
More than 72% of our employees surveyed have a connection to diabetes, whether they're living with it themselves or through family members and friends.
We show up each day to help make the lives of our coworkers and loved ones easier.
What we do
We’re shaping the future of diabetes care by engineering advanced diabetes solutions. With options ranging from insulin pump therapy to smart insulin injections, we provide solutions to meet our customers where they are in their diabetes journey. And it’s more than just our products. We want to help build a stronger support network too. That means offering customer service that’s always available when you need it, and helping unite our community of customers as #MiniMedChampions.
Introducing MiniMed,
our new product portfolio brand
We're uniting all of our therapies under one name and updating our look and feel to be simpler and more personal to create a better experience for our customers. MiniMed was designed around and for our community of #MiniMedChampions, celebrating the resilience, individuality, and everyday strength of people living with diabetes.
While the brand identity is new, our purpose remains the same: to simplify diabetes management and empower people to live life to the fullest.
We want to be an extraordinary partner for those living with diabetes.
“Our new MiniMed brand is more than just a name or logo — it’s a reflection of how we’re showing up differently for the diabetes community. It’s our way of saying: you’re at the heart of everything we do. As our brand grows and evolves, we’re committed to being the best partner we can be for everyone who chooses MiniMed — today and into the future."
- Que Dallara, EVP & President, Diabetes Operating Unit
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
The MiniMed 780G insulin pump is indicated for use by patients age 7-80 years with Type 1 diabetes, whose total daily dose of insulin is 8 units per day or more. The MiniMed 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.
Automated insulin delivery is made possible through combining Medtronic insulin pump and continuous glucose monitoring technology. Some user interaction required. Individual responses to the treatment can and do vary Consult a healthcare professional to see if this product is suitable for you.
The Guardian 4 sensor is intended for use with the Guardian 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is designed to replace fingerstick blood glucose (BG)readings for diabetes treatment decisions. The sensor is intended for insertion into persons ages 7 years and older. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 7 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.